Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response

Exclusion Criteria

• •1. Elevated fasting blood glucose (above 6.1 mmol/L at fasting on visit 1, 2, 3 or 4)
• •2. Women who are pregnant or breast feeding
• •3. Any medical condition(s) or medication(s) known to significantly affect glucose metabolism. Significance to be assessed by the QI
• •4. Use of medication, over-the-counter medication, natural health products or dietary supplements/probiotics that may affect glucose metabolism is prohibited during this study. Significance to be assessed by the QI. Participants who are taking allowed prescribed medications must agree to maintain their current method and dosing regimen during the course of the study unless other is recommended by their physician.
• •5. Known Type I or Type II diabetes, including women who previously have had gestational diabetes.
• •6. Use of antibiotics within 2 weeks of enrollment
• •7. Metabolic diseases and/or chronic gastrointestinal diseases (IBS, Crohns etc.)
• •8. Allergy to ingredients included in investigational product, reference, or standardized meal
• •9. Participants restricted to a vegetarian or vegan diet
• •10. Intolerance to gluten
• •11. Individuals who are averse to venous catheterization or capillary blood sampling
• •12. Currently active smokers (or using other tobacco products, and e-cigarettes)
• •13. Unstable medical conditions as determined by QI
• •14. Participation in other clinical research trials
• •15. Individuals who are cognitively impaired and/or who are unable to give informed consent
• •16. Acute infection
• •17. Any other condition which in the QI's opinion may adversely affect the individual's ability to complete the study or its measures or which may pose significant risk to the individual
• •\-